Curiosity plus innovation—Carebook secures a research grant to discover how AI inside a mobile app can deliver a patient-centric approach to improve medication adherence.`
Innovation is a key pillar at Carebook, a Montreal-based tech company has a live pharmacy platform that includes state-of-the-art features like retail and loyalty, online medication refills, health and wellness, and more. And now, with the help of a research grant, the team is diving deep into a new component that could benefit pharmacists, patients, and global health outcomes: medication adherence.
“To-date, most digital solutions for medication adherence focus on patient monitoring rather than on providing patient-centered care.” The Carebook team believes there is a better, personalized, patient-centered approach to this multi-billion dollar problem. “A patient-centered approach means incorporating patient needs, preferences, beliefs, concerns, and realities in medication management, and identifying personalized solutions to combat adherence barriers. We proposed to investigate how AI inside a mobile app could deliver a patient-centered approach to improve medication adherence.” Carebook plans to investigate and identify the adherence trajectories and proactively communicate with users to change that trajectory.
The team is thrilled that they’ve been awarded a grant by Prompt to start this patient-centric AI research. Prompt’s mission is to “increase the competitive advantage of Québec companies in the information and communications technology (ICT) sector through R&D partnerships with the institutional research community.” Carebook has teamed up with another Canadian start-up and known researchers in the field to complete this project.
Carebook CEO, Pascale Audette says the research is set to begin right away. “Our diverse, driven team of people values innovation. We want to make the world a better place with patient-centric health solutions so we’re excited to tackle medication adherence, one of the biggest issues in patient care.”
Medication adherence, defined by the World Health Organization as “the degree to which the person’s behavior corresponds with the agreed recommendations from a health care provider” deserves attention. The cost of medication non-adherence is astronomical, in terms of dollars—up to USD50,000 per person, according to a global review study (1)—and in health outcomes. Globally, it’s estimated that among patients with chronic illness, approximately 50% do not take medications as prescribed.(2)
Carebook’s team is made up of researchers, health professionals, engagement experts, and tech professionals. Their digital pharmacy platform is patient-centered, pharmacist-friendly, and can be white-labeled. If you’re a pharmacy, pharmacy franchise, or are interested in looking at our pharmacy solutions, we’re always happy to talk about the future of care.
- Cutler RL, Fernandez-Llimos F, Frommer M, et al Economic impact of medication non-adherence by disease groups: a systematic review BMJ Open 2018;8:e016982. doi: 10.1136/bmjopen-2017-016982